ISOFOL Share Price Performance
SEK 0.67
-1.18 (-63.62%)
Price SEK 0.67
Share Pricen/a
Isofol Medical AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
ISOFOL Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Isofol Medical AB (publ) Key Details
About ISOFOL
- Founded
- 2008
- Employees
- 6
- CEO
- WebsiteView website
Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.
